The SNS records neural activity from 60 channels across four brain regions--an order-of-magnitude increase over commercially available devices. The NeuroPace RNS system, FDA-cleared for epilepsy, ...
Saluda Medical, Inc. (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing ...
"Nia Therapeutics publishes first in vivo validation of SNS" was originally created and published by Medical Device Network, ...
Neuropsychiatric disorders, such as depression and ADHD, remain a global health burden, with current treatments often limited by individual variability and insufficient long-term efficacy. In a ...
Nia Therapeutics announced the publication of the first in vivo validation of its wireless, implantable brain-computer ...
Please provide your email address to receive an email when new articles are posted on . The potential for deep brain stimulation rests in the ability for accurate location of biomarkers. Personalized ...
Spinal cord injury (SCI) rostral to the lumbar locomotor center disrupts communication between the brain and the spinal circuits that control leg movements, leading to paraplegia. A research team led ...
Professor Gustafson's research is in the areas of neural engineering and neural prostheses. His research interests focus on understanding the systems-level neurophysiology and neural control of pelvic ...
Schematic illustration of the noninvasive closed-loop spinal interface. Hand muscle activity is recorded by surface electrodes and converted into trigger pulses for magnetic stimulation applied over ...